SNBL

Kagoshima,  Kagoshima 
Japan
https://www.snbl.co.jp

SNBL welcomes our fellow partners and experts to ACT 2022.

The mission of SNBL Group is to free patients from suffering by supporting drug development and improving medical technology.

The preclinical research division of SNBL is Japan’s largest and oldest preclinical CRO. For over 65 years, we have balanced speed with superior quality, carrying out studies efficiently, accurately and in a timely manner, consistently exceeding our customers’ expectations; because this is not just a job, it’s our passion.

At SNBL, we embrace the challenges of innovation, growth and development in order to provide a meaningful contribution to the well-being of all people.

Copyright © 2022 American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, Code of Conduct, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy | Code of Conduct | Provide Consent | Unsubscribe